Steven A. Ledger - 26 May 2026 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: SER
Reported as of: 26 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 May 2026, 15:55:18 UTC
Prior SEC filing: 26 May 2026
Source filing: View source filing
Reporting owner signature: Steven A. Ledger

Key filing fact

Steven A. Ledger filed Form 4 for Serina Therapeutics, Inc. (SER) on 27 May 2026.

Key facts

This page summarizes Steven A. Ledger's Form 4 filing for Serina Therapeutics, Inc. (SER).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 May 2026, 15:55.

Change

Previous filing in this sequence was filed on 26 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001090206 Primary reporting owner

LEDGER STEVEN A

Relationship: Chief Executive Officer, Director
Address: 601 GENOME WAY, SUITE 2001, HUNTSVILLE
Signature: Steven A. Ledger
Signature date: 27 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SER transaction

Common Stock

Award

Transaction value
Shares: +10,100
Change %
Price: $1.93^*
Shares after: 10,100
Date: 26 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reflects the weighted average purchase price of multiple transactions ranging from a low purchase price of $1.87 per share to a high purchase price of $1.95 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price.